818 related articles for article (PubMed ID: 30427062)
1. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.
Fettig NM; Osborne LC
Microbes Infect; 2021; 23(6-7):104814. PubMed ID: 33775860
[TBL] [Abstract][Full Text] [Related]
4. Matrine Mediated Immune Protection in MS by Regulating Gut Microbiota and Production of SCFAs.
Dou M; Chu Y; Zhou X; Wang M; Li X; Ma R; Fan Z; Zhao X; Wang W; Li S; Lv Y; Zhu L
Mol Neurobiol; 2024 Jan; 61(1):74-90. PubMed ID: 37581848
[TBL] [Abstract][Full Text] [Related]
5. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
[TBL] [Abstract][Full Text] [Related]
6. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
7. CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice.
Chitrala KN; Guan H; Singh NP; Busbee B; Gandy A; Mehrpouya-Bahrami P; Ganewatta MS; Tang C; Chatterjee S; Nagarkatti P; Nagarkatti M
Eur J Immunol; 2017 Jul; 47(7):1188-1199. PubMed ID: 28543188
[TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
9. The role of the gut microbiota and microbial metabolites in neuroinflammation.
Haase S; Wilck N; Haghikia A; Gold R; Mueller DN; Linker RA
Eur J Immunol; 2020 Dec; 50(12):1863-1870. PubMed ID: 33188704
[TBL] [Abstract][Full Text] [Related]
10. Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota.
Lu XY; Han B; Deng X; Deng SY; Zhang YY; Shen PX; Hui T; Chen RH; Li X; Zhang Y
Gut Microbes; 2020 Nov; 12(1):1857515. PubMed ID: 33382357
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Berer K; Gerdes LA; Cekanaviciute E; Jia X; Xiao L; Xia Z; Liu C; Klotz L; Stauffer U; Baranzini SE; Kümpfel T; Hohlfeld R; Krishnamoorthy G; Wekerle H
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10719-10724. PubMed ID: 28893994
[TBL] [Abstract][Full Text] [Related]
12. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
13. Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.
Han B; Shi L; Bao MY; Yu FL; Zhang Y; Lu XY; Wang Y; Li DX; Lin JC; Jia W; Li X; Zhang Y
Microbiome; 2024 Jun; 12(1):114. PubMed ID: 38915127
[TBL] [Abstract][Full Text] [Related]
14. Disease of the holobiont, the example of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Med Clin (Barc); 2019 Feb; 152(4):147-153. PubMed ID: 30424933
[TBL] [Abstract][Full Text] [Related]
15. Role of intestinal microbiota in the development of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Neurologia; 2017 Apr; 32(3):175-184. PubMed ID: 26383059
[TBL] [Abstract][Full Text] [Related]
16. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota depletion from early adolescence alters adult immunological and neurobehavioral responses in a mouse model of multiple sclerosis.
Zeraati M; Enayati M; Kafami L; Shahidi SH; Salari AA
Neuropharmacology; 2019 Oct; 157():107685. PubMed ID: 31247271
[TBL] [Abstract][Full Text] [Related]
18. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
Mowry EM; Glenn JD
Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
Xu L; Zhang C; He D; Jiang N; Bai Y; Xin Y
Life Sci; 2020 Jul; 253():117747. PubMed ID: 32376270
[TBL] [Abstract][Full Text] [Related]
20. Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis.
Calvo-Barreiro L; Eixarch H; Cornejo T; Costa C; Castillo M; Mestre L; Guaza C; Martínez-Cuesta MDC; Tanoue T; Honda K; González-López JJ; Montalban X; Espejo C
Neurotherapeutics; 2021 Apr; 18(2):920-937. PubMed ID: 33829410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
